Skip to main content
Clinical Trials/KCT0008041
KCT0008041
Recruiting
未知

A human study to evaluate the effectiveness and safety of propolis extract on skin condition improvement in children with atopic dermatitis: a randomized, double-blind, parallel, placebo-controlled study

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the skin and subcutaneous tissue
Sponsor
Seoul National University of Science and Technology
Enrollment
84
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Subject who voluntarily agrees to participate and subjects and their parents (or legal representatives) sign in informed consent form
  • 2\) The ages of between 4 and 65 with intermittent or persistent symptoms of atopic dermatitis for more than 6 months

Exclusion Criteria

  • 1\) Subjects who have systemic diseases such as skin diseases except for atopic dermatitis, immunodeficiency, autoimmune diseases, cancer, etc.
  • 2\) Use of systemic antibiotics, corticosteroids, or immunosuppressants related to atopic dermatitis within 1 month of the first visit
  • 3\) Use of medication related atopic dermatitis such as antihistamines, herbal medicines, or health functional foods within 1 month of the first visit
  • 4\) Presence of received phototherapy within 1 month of the first visit
  • 5\) History of hypersensitivity including ingredients (propolis, honey) or pollen in the placebo/test material, or severe food allergic reactions
  • 6\) Subjects who plan to participate in another clinical trial during current participation
  • 7\) Participation in another clinical trial within 1 month of the first visit
  • 8\) Subjects who, in the investigator's judgment, have a condition that would not allow to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials